Acquisition of the worldwide adult medical nutrition business of Mead Johnson and Company, a subsidiary of Bristol-Myers Squibb, is announced.
A majority interest in Idenix Pharmaceuticals, Inc., a
US-based biotech company focused on antiviral and anti-infective therapies, is acquired as part of a strategic expansion into antiviral medicines.